Cargando…
基于"分子分期"的局部晚期非小细胞肺癌"个体化外科治疗"的长期生存结果
BACKGROUND AND OBJECTIVE: Approximately 35%-40% of patients with newly diagnosed non-small cell Lung cancer have locally advanced disease. The average survival time of these patients only have 6-8 months with chemotherapy. The aim of this study is to explore and summarize the probability of detectio...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999764/ https://www.ncbi.nlm.nih.gov/pubmed/21342639 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.02.15 |
Ejemplares similares
-
基于标准化术语的胸外科结构化电子病历实践
Publicado: (2018) -
肺癌的个体化靶向治疗
por: Wu, Kehua, et al.
Publicado: (2013) -
HIV合并肺癌的个体化综合治疗
Publicado: (2018) -
中国易瑞沙扩大用药项目中晚期非小细胞肺癌长期生存患者的研究
Publicado: (2012) -
非小细胞肺癌个体化治疗相关分子标记物
Publicado: (2011)